NEW YORK, NEW York – Updated with new information on the effectiveness of HBOT to treat Traumatic Brain Injury (TBI), The Oxygen Revolution proves a powerful resource for knowledge of this unique therapeutic modality.
Hyperbaric Oxygen Therapy (HBOT) is based on a simple idea—that oxygen can be used therapeutically for a wide range of conditions where tissues have been damaged by oxygen deprivation. Research has shown that HBOT directly affects the body at the genetic level, affecting over 8,000 individual genes—those responsible for healing, growth, and anti-inflammation.
Leading expert Dr. Paul G. Harch’s research and clinical practice has shown that HBOT’s noninvasive and painless treatment can help those suffering from Traumatic Brain Injury (TBI) or such diseases as stroke, autism, cerebral palsy, Alzheimer’s, Parkinson’s disease, multiple sclerosis, and emergency situations requiring resuscitation, such as cardiac arrest, carbon monoxide poisoning, or near drowning.
For those affected by these seemingly “hopeless” diseases, there is finally hope in a proven solution: HBOT. Visit www.HBOT.com.
Paul G. Harch, M.D. is a hyperbaric medicine, diving, and emergency medicine physician and Diplomate of the American Board of Hyperbaric Medicine. The first President of the International Hyperbaric Medical Association and a semi-finalist for the National Institutes of Health Director’s Pioneer Award, he has seen the positive effects of HBOT firsthand through the treatment of family members with stroke, dementia, and learning disability. A graduate of Johns Hopkins University School of Medicine and Director of the Louisiana State University School of Medicine’s Hyperbaric Medicine Department, Dr. Harch currently divides his time between international consulting, lecturing, and his practice and research in the New Orleans area.
